Copyright
©The Author(s) 2022.
World J Transplant. Nov 18, 2022; 12(11): 378-387
Published online Nov 18, 2022. doi: 10.5500/wjt.v12.i11.378
Published online Nov 18, 2022. doi: 10.5500/wjt.v12.i11.378
Table 1 Study population characteristics (n = 131)
| Item | Value |
| Age, yr (mean ± SD) | 53.27 ± 12.71 |
| Gender | |
| Male | 93 (70.9%) |
| Female | 38 (29.1%) |
| Transplant type | |
| Liver | 90 (68.7%) |
| Kidney | 36 (27.5%) |
| SPKT | 4 (3.0%) |
| SLKT | 1 (0.8%) |
| Virology results | |
| B19V DNA positive | 0 (0%; one-sided 97.5% CI: 0-2.8) |
| B19V IgM positive | 0 (0%; one-sided 97.5% CI: 0-2.8) |
| IgG B19V positive | 101 (77.1%; 95% CI: 68.9-83.9) |
- Citation: Simunov B, Mrzljak A, Jurekovic Z, Zidovec Lepej S, Bainrauch A, Pavicic Saric J, Hruskar Z, Radmanic L, Vilibic-Cavlek T. Parvovirus B19 status in liver, kidney and pancreas transplant candidates: A single center experience. World J Transplant 2022; 12(11): 378-387
- URL: https://www.wjgnet.com/2220-3230/full/v12/i11/378.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i11.378